Clinical Trial Update: MLN518 in Combination With Standard Induction Chemo. for Treatment of Patients With Newly Diagnosed Acute Myelogenous Leukemia [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated MLN518 in combination with standard induction chemotherapy in patients with newly diagnosed acute myeloid leukemia. The study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• MLN518

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Acute Myelogenous Leukemia | Phase 1 | Status: COMPLETED